Literature DB >> 24656672

Detection of human papillomavirus in nonmelanoma skin cancer lesions and healthy perilesional skin in kidney transplant recipients and immunocompetent patients.

J Bernat-García1, M Morales Suárez-Varela2, J J Vilata-Corell3, A Marquina-Vila4.   

Abstract

BACKGROUND: The influence of human papillomavirus (HPV) on the development of nonmelanoma skin cancer (NMSC) is a topic of debate. HPV types from the beta genus (HPV-β) have been most frequently associated with the development of skin cancer.
OBJECTIVES: To analyze the prevalence and range of HPV types in NMSC lesions and healthy perilesional skin in immunodepressed and immunocompetent patients and to evaluate the influence of various clinical factors on the prevalence of HPV in skin cancer.
METHODS: Nested polymerase chain reaction and sequencing were used to detect HPV in 120 NMSC samples obtained by biopsy from 30 kidney transplant recipients and 30 immunocompetent patients. In all cases, a sample was taken from the tumor site and the surrounding healthy skin. Potential confounders were assessed and the data analyzed by multivariate logistic regression.
RESULTS: HPV DNA was detected in 44 (73.3%) of the 60 samples from immunodepressed patients and in 32 (53.3%) of the 60 samples from immunocompetent patients (adjusted odds ratio, 3.4; 95% CI, 1.2-9.6). In both groups of patients, HPV was more common in healthy perilesional skin than in lesional skin. HPV-β was the most common type isolated.
CONCLUSION: We found a wide range of HPV types (mostly HPV-β) in the skin of kidney transplant recipients and immunocompetent patients with skin cancer.
Copyright © 2013 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Keywords:  Basal cell carcinoma; Carcinoma basocelular; Carcinoma epidermoide; Cáncer de piel no melanoma; Human papillomavirus; Immunosuppression; Inmunosupresión; Nonmelanoma skin cancer; Polymerase chain reaction; Reacción en cadena de la polimerasa; Squamous cell carcinoma; Virus del papiloma humano

Mesh:

Year:  2014        PMID: 24656672     DOI: 10.1016/j.adengl.2013.10.008

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  6 in total

1.  First Detection of Human Papillomaviruses and Human Polyomaviruses in River Waters in Italy.

Authors:  M Iaconelli; S Petricca; S Della Libera; P Di Bonito; G La Rosa
Journal:  Food Environ Virol       Date:  2015-06-07       Impact factor: 2.778

2.  Immune Modulation and Treatment of Human Papilloma Virus-Related Warts with Energetics of Living Systems Acupuncture.

Authors:  Rom Brustin; Martine Toledano; Tal Geffen; Raia Goona; Malka Hochberg; Bilha Kreisberg; Sari Murad; Jacob Pitcovski
Journal:  Med Acupunct       Date:  2017-06-01

3.  Prevalence and incidence of anal human papillomavirus infection in Mexican men: Need for universal prevention policies.

Authors:  Hector Posso; Leith León-Maldonado; Betania Allen-Leigh; Jorge Salmerón; Manuel Quiterio; Anna R Giuliano; Staci L Sudenga; Alan G Nyitray; B Nelson Torres; Martha Abrahamsen; Eduardo Lazcano-Ponce
Journal:  Salud Publica Mex       Date:  2018 Nov-Dec

4.  Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience.

Authors:  Mehmet Turkeli; Melih Simsek; Mehmet Naci Aldemir; Nilgun Yildirim; Erdem Cankaya; Burak Erdemci; Mehmet Bilici; Salim Basol Tekin; Sukru Arslan; Ercan Korkut
Journal:  Eurasian J Med       Date:  2016-02

Review 5.  A Systematic Review and Meta-Analysis: Evaluation of the β-Human Papillomavirus in Immunosuppressed Individuals with Cutaneous Squamous Cell Carcinoma.

Authors:  Mazaher Ramezani; Farideh Baharzadeh; Afshin Almasi; Masoud Sadeghi
Journal:  Biomedicine (Taipei)       Date:  2020-12-01

6.  Human papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen's disease.

Authors:  Marián Švajdler; Roman Mezencev; Jana Kašpírková; Denisa Kacerovská; Dmitry V Kazakov; Ondrej Ondič; Michal Michal
Journal:  Diagn Pathol       Date:  2016-06-24       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.